RadNet Acquires Gleamer for €230 Million, Projects $30 Million AI Revenue
RadNet has acquired Paris-based AI imaging firm Gleamer for up to €230 million, integrating FDA-cleared BoneView and ChestView algorithms into its DeepHealth suite. The deal is expected to drive approximately $30 million in annualized recurring AI revenue in 2026 and expand commercial deployment across routine imaging.
1. Acquisition Details
RadNet completed acquisition of Gleamer for up to €230 million, acquiring its FDA-cleared BoneView and ChestView X-ray algorithms. The purchase integrates Gleamer into RadNet's DeepHealth division, creating the largest radiology-focused clinical AI provider globally.
2. AI Portfolio Expansion
The deal adds Gleamer's AI-driven bone fracture and chest pathology detection to DeepHealth’s existing mammography, lung and prostate solutions. This expanded portfolio addresses rising imaging volumes and clinician shortages by automating high-volume workflows.
3. Financial Impact and Outlook
The combined entity is projected to generate around $30 million in annualized recurring AI revenue in 2026. RadNet plans commercial deployment across over 2,000 facilities, targeting routine imaging to drive subscription-based revenue growth.